ERF.PA - Eurofins Scientific SE

Paris - Paris Delayed Price. Currency in EUR

Eurofins Scientific SE

23 Val Fleuri
Luxembourg 1526

IndustryMedical Laboratories & Research
Full Time Employees26,634

Key Executives

Dr. Gilles G. Martin Ph.D.Chairman and Chief Exec. Officer960.4kN/A54
Mrs. Valerie HanoteExec. Director239.69kN/A50
Dr. Yves-Lo�c MartinExec. Director332kN/A50
Mr. Dirk BontridderGroup Exec. VP of Pres Pharmaceutical Services and Member of Management BoardN/AN/A44
Dr. Markus BrandmeierGroup Exec. VP of Food Testing and Member of The Exec. BoardN/AN/A53
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.


Eurofins Scientific SE provides various analytical testing services worldwide. It offers a portfolio of approximately 130,000 analytical methods for evaluating the safety, identity, composition, authenticity, origin, traceability, and purity of biological substances and products. The company provides food and feed testing, biopharma, genomic, agroscience, agro testing, consumer product testing, environment testing, clinical diagnostics, environment testing, forensic, medical device testing, and genomic services, as well as chemicals registration, evaluation, and authorization services. It serves the pharmaceutical, food, environmental, and consumer products industries, as well as governments. The company operates approximately 310 laboratories in 39 countries. Eurofins Scientific SE was founded in 1987 and is headquartered in Luxembourg.

Corporate Governance

Eurofins Scientific SE’s ISS Governance QualityScore as of February 1, 2018 is 9. The pillar scores are Audit: 1; Board: 9; Shareholder Rights: 6; Compensation: 6.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.